Tag: Andy Boral

CHMP adopts positive opinion for avapritinib for PDGFRA D842V mutant GIST

pharmanewsdaily- July 26, 2020

US precision therapy company Blueprint Medicines said that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a ... Read More